H.U. Group Holdings Inc

Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:

Sign Up

Direct Lobbying Transparency

Overall Assessment	Comment	Score
Limited	H.U. Group provides only a basic picture of its climate-policy lobbying. It states that it participates in coalitions such as the Japan Climate Initiative and the Keidanren Carbon Neutrality Action Plan and that it "proactively lobby the government to introduce relevant public policies and regulations," but it does not identify any particular bill, regulation, or rule it has addressed, referring instead to broad themes such as renewable energy, carbon pricing and alignment with the Paris Agreement. The mechanisms it discloses are similarly high-level: the company mentions publishing joint messages through JCI—including the call that "JCI calls on the Japanese government to set an ambitious 2035 target that is consistent with the 1.5-degree goal"—yet it gives no detail about whether it met officials, sent letters or submitted consultation responses, and the only target it names is the Japanese government in general. Finally, the outcomes it seeks are framed in broad aspirations such as net-zero emissions by 2050 and stronger interim targets; no concrete legislative amendments, numerical carbon price levels, or other measurable policy changes are specified. Overall, the disclosure shows that the company is engaged and supportive of stronger climate action but offers limited transparency on the specific policies, lobbying channels, or detailed objectives of that engagement.	1

Lobbying Governance

Overall Assessment	Comment	Score
Moderate	H.U. Group has implemented a structured governance process for ensuring that its climate-related engagement activities align with its climate commitments. It requires that policy-influencing engagements be reported to the environment and energy subcommittee and, where needed, be decided by the Sustainability Committee chaired by the Group CEO, demonstrating clear oversight by a named senior executive. The company also periodically check[s] for any major inconsistencies or deviations in its memberships of industry associations and will consider withdrawing from the association if a significant discrepancy is found, indicating active management of indirect lobbying. However, the disclosure does not provide evidence of a published lobbying-alignment audit or review, nor does it explain in detail how the company monitors the consistency of its own direct lobbying positions with its climate strategy; references to alignment are limited, focused on its participation in the Japan Climate Initiative and The Federation of Pharmaceuticals Associations of Japan.	2